NASDAQ:RIGL

Rigel Pharmaceuticals Stock Forecast

etoro logo Buy RIGL
*Your capital is at risk
$41.66
+1.49 (+3.71%)
At Close: Aug 10, 2026

Should you buy RIGL stock?

Last updated:

Based on market data through , StockInvest.us rates Rigel Pharmaceuticals (RIGL) as a Buy Candidate with a technical score of 2.23 on its -10 to +10 scale. This is an upgrade from Hold in the previous daily evaluation.

  • Buy signal since
  • Price since signal Up 2.92%
  • 3-month trend forecast Up 40.19%
  • Buy Candidate 2.23
AI Analysis AI Analysis of RIGL AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RIGL to Watchlist?
Some Reasons Why To Add RIGL:
  • High gross margin of 91.4%
  • Strong return on equity of 96.5%
  • Strong operating margin of 31.5%
PDF

Stronger technical forecast for Rigel Pharmaceuticals stock price after Monday trading
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Aug 05, 2026 Gain 2.92%

The Rigel Pharmaceuticals stock price gained 3.71% on the last trading day (Monday, 10th Aug 2026), rising from $40.17 to $41.66. During the last trading day the stock fluctuated 4.66% from a day low at $39.93 to a day high of $41.79. The price has risen in 7 of the last 10 days and is up by 11.42% over the past 2 weeks. Volume fell on the last day by -85 thousand shares and in total, 230 thousand shares were bought and sold for approximately $9.60 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 40.19% during the next 3 months and, with a 90% probability hold a price between $53.50 and $68.30 at the end of this 3-month period.

RIGL Signals & Forecast

The Rigel Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $39.21 and $39.27. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -4.80%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Rigel Pharmaceuticals stock

Rigel Pharmaceuticals finds support from accumulated volume at $40.48 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.86 between high and low, or 4.66%. For the last week, the stock has had daily average volatility of 6.91%.

Our recommended stop-loss: $40.19 (-3.53%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 22 days ago.)

Trading Expectations (RIGL) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Rigel Pharmaceuticals to open at $41.13, and during the day (based on 14 day Average True Range), to move between $40.64 and $42.68, which gives a possible trading interval of +/-$2.04 (+/-5.03%) up or down from last closing price. If Rigel Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 5.03% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $41.67 (0.02%) than the support at $40.48 (2.83%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Rigel Pharmaceuticals stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Rigel Pharmaceuticals stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.234 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $41.13 ( 1.28%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RIGL Performance

Trading levels for RIGL

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 42.99 3.18%
R2 42.28 1.48%
R1 41.84 0.425%
Price 41.66
S1 40.42 -2.99%
S2 39.98 -4.04%
S3 39.27 -5.74%

Accumulated Volume Support & Resistance Levels

Level Price
R3 42.56 2.16%
R2 42.55 2.14%
R1 41.67 0.0240%
Price 41.66
S1 40.48 -2.83%
S2 38.69 -7.13%
S3 32.13 -22.88%

FAQ

What is the symbol for Rigel Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Rigel Pharmaceuticals is RIGL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Rigel Pharmaceuticals Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Rigel Pharmaceuticals (RIGL) as a Buy Candidate with a technical score of 2.23 on its -10 to +10 scale. This is an upgrade from Hold in the previous daily evaluation. Since the Buy signal began on Aug 05, 2026, the price has risen 2.92%. The current 3-month trend forecast projects a rise of 40.19%.

How to buy Rigel Pharmaceuticals Stock?
Rigel Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rigel Pharmaceuticals Stock.

What's the current price of Rigel Pharmaceuticals Stock?
As of the end of day on the Aug 10, 2026, the price of an Rigel Pharmaceuticals (RIGL) share was $41.66.

What is the 52-week high and low for Rigel Pharmaceuticals Stock?
The 52-week high for Rigel Pharmaceuticals Stock is $52.06 and the 52-week low is $24.95.

What is the market capitalization of Rigel Pharmaceuticals Stock?
As of the Aug 10, 2026, the market capitalization of Rigel Pharmaceuticals is 770.797M.

When is the next earnings date for Rigel Pharmaceuticals?
The upcoming earnings date for Rigel Pharmaceuticals is Nov 03, 2026.
Click to get the best stock tips daily for free!
ABOUT RIGEL PHARMACEUTICALS
Rigel Pharmaceuticals
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is in phase III clinical trial for the treatment of warm autoimmune hemolytic anemia; phase III clinical t...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE